Company is managed by the Board of directors who are highly technical qualified with vast experience in the field of pharmaceuticals and diagnostics. The Board oversees the conduct and supervises the management affairs of HiGlance with the Company's pool of Scientists, Doctors, Technocrats, Engineers, Legal and Financial advisers, marketing analysts. Before the start of each financial year, the Board approves HiGlance annual budget and strategic objectives. The board reviews the company's internal controls and risk management policies and approves its governance structure and code of ethics. The Board meets regularly to consider particular issues or conduct specific reviews whenever deemed appropriate. The board appraises and approves major financing, investment and contractual decisions in excess of defined thresholds. In addition, the board evaluates and monitors the performance of the group as a whole and also keep monitoring on world's science & research achievement, financial & political changes to update us to face the challenges.


News & Events

- HiGlance Laboratories entered into Cardio & Diabetic segment with the launch of "CD Care" division to cater millions of people suffering from Cardio & Diabetes diseases.

- HiGlance Laboratories is partcipating(one of the major sponsor) in RSSDI-2016 at Jhansi, UPCSI 2016 (Cardicon) at Agra, UPAPICON 2016 at Allahabad.

- HiGlance entered into liquid oral segment and already started commercial production. Our product range includes Antibiotics, Antipyretic, Anti-inflammatory, Analgesic, Ant allergy, Cough Preparations, Multivitamins etc.

- HiGlance entered in chain pharmacy segment & started catering to approx 4 million people in India.

- HiGlance Laboratories designed Calcium combination with a unique new technology called "Dispersion Technology", which ensures early absorption & faster dissolution with delicious orange flavor.